Searchable abstracts of presentations at key conferences in endocrinology

ea0041gp210 | Thyroid - Translational & Clinical (1) | ECE2016

The expression of co-stimulatory receptor SLAMF-1 in lymphocytes from patients with autoimmune thyroiditis

Sampedro-Nunez Miguel , Vitales-Noyola Marlen , Serrano-Somavilla Ana , Di Pasquale Carmelina , Hernandez-Martinez Rebeca , Ramos-Levi Ana , Gonzalez-Amaro Roberto , Marazuela Monica

Introduction: Signalling lymphocytic activation molecule SLAMF1 (CD150) is a modulatory receptor expressed in most immune cells. Different data indicate that CD150 is involved in T cell cytokine production, NK cell and CD8 T cell mediated cytotoxicity, and T regulatory (Treg) cell activity. Patients with autoimmune thyroid disease (AITD) show defects in their immune-regulatory mechanisms. Herein we assessed the expression and function CD150 in lymphocytes subpopulations from p...

ea0037ep1059 | Thyroid (non-cancer) | ECE2015

Serum Galectins are increased in patients with Graves' disease hyperthyroidism

Ramos-Levi Ana M , Serrano Ana , Sampedro-Nunez Miguel A , Vicuna Alicia , Rodriguez-Munoz Ana , Martinez Rebeca , De la Fuente Hortensia , Marazuela Monica

Introduction: Patients with autoimmune thyroid disease (AITD) exhibit aberrant immune-regulatory mechanisms. Galectins (Gal) are a family of glycan-binding proteins, which have been involved in immune regulation. However, the association of Gal with AITD remains unknown. In this study, we evaluated serum Gal-1 and Gal-9 in patients with AITD.Methods: Peripheral blood samples from 31 patients with GravesÂ’ disease (GD) (14 with untreated hyperthyroidi...